IL17A and hypertensive disorder: Subsequent mediation analysis identified 5 potential mediators, with weight contributing the most at 30.3%, followed by IL-17 (17.2%), TNF (14.08%), coronary atherosclerosis (13.4%), and hypertension (11.6%).